In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Delay until end of 2025 for German on label food supplements

Delay until end of 2025 for German on label food supplements

by In2Pharma | Jan 13, 2025 | News

Belgium The use of German on labels in the German-speaking community was not made compulsory from 1 January 2025. Minister Clarinval agreed to extend the current tolerance policy by one year, until the end of 2025. Until then, the FASFC (Federal Agency for the Safety...

Recent Posts

  • Update NDS-web platform
  • Maximum limits nutrients food supplements
  • Maximum hospitality limits increased
  • CGR publishes new maximum hourly rates for 2027
  • GAIA self-assessment on hospitality rules now also applies to medical device companies

Follow Us

  • Facebook
  • LinkedIn
An IQVIA Business

IQVIA Logo
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations.

www.iqvia.com

Contact Us

Privacy Policy | Your Privacy Choices | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com |Terloonststraat 22, 1910 Kampenhout, België